The new seed technology offers growers a significant boost in productivity and resilience, even in stressful, water-limited environments.
Advancing a selective oral NMDA receptor modulator toward Phase 2a in chemotherapy-induced peripheral neuropathy following favorable Phase 1 safety and tolerability findings ...
In an open-label study of 29 men, including patients with ulcerative colitis and Crohn’s disease in remission, 6 g per day of curcumin for eight weeks led to modest, transient shifts in gut microbiota ...
In this single-center ambispective cohort of 283 Polish patients with COVID-19–related ARDS requiring invasive mechanical ventilation, cumulative mortality reached 44.5% at four years after ICU ...
YSO helps event and service businesses scale with vetted VAs, structured onboarding, and operational systems that ...
AI will only deliver real business impact when it is trusted to be deployed at scale, which requires the same rigor as ...
In a move widely regarded as a defining step in Liberia's digital transformation journey, the Liberia Telecommunications Authority (LTA) has officially granted a Value-Added Services (VAS) License "C" ...
Chief Scientific Officer Raj Patil, Ph.D., will share the data in a presentation titled: "First-in-Human Study of Urcosimod to Treat Neuropathic Corneal Pain (NCP) Shows Clinically Meaningful Pain ...
Patient and Caregiver Perceptions of an Interface Design to Communicate Artificial Intelligence–Based Prognosis for Patients With Advanced Solid Tumors Clinical trial data were used and contained ...
Abstract: The quantification and analysis of conversational nuances is a complex and demanding task in the fields of natural language processing and human-computer interaction. In this paper, a novel ...
Scale AI is suing the Department of Defense, filing its complaint on January 30. The nature of the dispute is unclear, and case documents are expected to include classified information. Scale AI is ...
Introduction This study aims to validate the Seizure-Related Impact Assessment Scale (SERIAS). This novel patient-reported outcome measure (PROM) compares the ‘trade-off’ between seizures and ...